Tislelizumab Injection Clinical Trials

3 actively recruiting trials

No change since May 2026

Also known as: Tislelizumab

Pipeline

Phase 2: 3

Top Sponsors

Nanjing Leads Biolabs Co.,Ltd2
Ji Yongling1

Indications

Cancer3
Advanced Solid Tumour2
Lung Cancer1
Non Small Cell Lung Cancer1

Other3 trials

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Phase 2

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Phase 2

Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.